Acerus Pharmaceuticals seeks expert advice from Novateur to improve characteristics of the Active Product Ingredients (API) and formulation of their approved products
Since 2019, the Novateur advisory team has been engaged to support Acerus to improve quality control and supply chain of their approved products.
Novateur assembled an experienced technical team that was able to identify and resolve issues at hand and improve the characteristics of the Active Product Ingredients (API) and the formulation.
The Novateur expert team identified qualified testing laboratories and API suppliers. The result of the testing and sourcing activities identified a path forward for Acerus to improve the product and device performance. In addition, critical process parameters were characterized to provide additional controls for future manufacturing.
Learn more about Acerus Pharmaceuticals Corporation